Opening book details…
About this Medicine article
107PD * AFATINIB (A) PLUS PACLITAXEL (P) FOLLOWING PROGRESSION ON A MONOTHERAPY IN PATIENTS (PTS) WITH METASTATIC NON-SMALL-CELL LUNG CANCER (NSCLC) WHO PREVIOUSLY BENEFITED FROM ERLOTINIB (E)/GEFITINIB (G): A GLOBAL RANDOMISED PHASE III TRIAL-LUX-LUNG 5 (LL5) by Schuler, M.; Yang, J. C.- H.; Park, K.; Chand, V. K.; Wang, B.; Planchard, D. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Schuler, M.; Yang, J. C.- H.; Park, K.; Chand, V. K.; Wang, B.; Planchard, D.
- Publisher
- Oxford University Press; Elsevier BV (ISSN 0923-7534)
- Published
- 2015
- Language
- EN
- Field
- Medicine (Health Sciences)
More by Schuler, M.; Yang, J. C.- H.; Park, K.; Chand, V. K.; Wang, B.; Planchard, D.
Browse all works by Schuler, M.; Yang, J. C.- H.; Park, K.; Chand, V. K.; Wang, B.; Planchard, D.